Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Sheldon, B. Grubb, B. Olshansky, W. Shen, Hugh Calkins, M. Brignole, S. Raj, A. Krahn, C. Morillo, J. Stewart, R. Sutton, P. Sandroni, K. Friday, D. Hachul, M. Cohen, D. Lau, K. Mayuga, J. Moak, R. Sandhu, Khalil Kanjwal (2015)
2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope.Heart rhythm, 12 6
C. Yancy, M. Jessup, B. Bozkurt, J. Butler, D. Casey, M. Drazner, G. Fonarow, S. Geraci, T. Horwich, J. Januzzi, Maryl Johnson, E. Kasper, W. Levy, F. Masoudi, P. Mcbride, J. McMurray, J. Mitchell, Pamela Peterson, B. Riegel, F. Sam, L. Stevenson, W. Tang, E. Tsai, B. Wilkoff (2013)
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.Circulation, 128 16
D. Saggu, V. Narain, S. Dwivedi, R. Sethi, S. Chandra, A. Puri, R. Saran (2015)
Effect of Ivabradine on Heart Rate and Duration of Exercise in Patients With Mild-to-Moderate Mitral Stenosis: A Randomized Comparison With MetoprololJournal of Cardiovascular Pharmacology, 65
U. Boeken, A. Assmann, A. Mehdiani, P. Akhyari, A. Lichtenberg (2012)
Ivabradine in patients with inappropiate sinus tachycardia after cardiac surgery: alternative to β-blockers?Thoracic and Cardiovascular Surgeon, 60
Gabriel Retegui, Mariola Quintero, Mariano Ruiz-Borrell, A. Revello (2009)
Ivabradine as a treatment option for inappropriate sinus tachycardia.Revista espanola de cardiologia, 62 5
G. Riccioni, L. Masciocco, A. Benvenuto, P. Saracino, D. Viti, F. Massari, G. Meliota, F. Buta, G. Speziale (2013)
Ivabradine Improves Quality of Life in Subjects with Chronic Heart Failure Compared to Treatment with β-Blockers: Results of a Multicentric Observational APULIA StudyPharmacology, 92
A. Guaricci, J. Schuijf, Filippo Cademartiri, N. Brunetti, D. Montrone, E. Maffei, C. Tedeschi, R. Ieva, L. Biase, M. Midiri, L. Macarini, M. Biase (2012)
Incremental value and safety of oral ivabradine for heart rate reduction in computed tomography coronary angiography.International journal of cardiology, 156 1
K. Swedberg, M. Komajda, M. Böhm, J. Borer, I. Ford, Ariane Dubost-Brama, G. Lerebours, L. Tavazzi (2010)
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled studyThe Lancet, 376
M. Luaces, A. Rodríguez-Benavente, I. Vilacosta, J. Martín (2009)
Thrombosis of an apparently normal thoracic aorta: another case, another conundrum.Revista espanola de cardiologia, 62 5
M. Manz, M. Reuter, G. Lauck, H. Omran, W. Jung (2003)
A Single Intravenous Dose of Ivabradine, a Novel If Inhibitor, Lowers Heart Rate but Does Not Depress Left Ventricular Function in Patients with Left Ventricular DysfunctionCardiology, 100
E. Bocchi, M. Böhm, J. Borer, I. Ford, M. Komajda, K. Swedberg, L. Tavazzi (2015)
Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT PopulationCardiology, 131
R. Kočková, J. Svatunkova, J. Novotný, L. Hejnova, B. Ošt̕ádal, D. Sedmera (2013)
Heart rate changes mediate the embryotoxic effect of antiarrhythmic drugs in the chick embryo.American journal of physiology. Heart and circulatory physiology, 304 6
R. Sutton, T. Salukhe (2011)
Ivabradine in the treatment of orthostatic intolerance.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 13 3
V. Schulze, S. Steiner, M. Hennersdorf, B. Strauer (2007)
Ivabradine as an Alternative Therapeutic Trial in the Therapy of Inappropriate Sinus TachycardiaCardiology, 110
(2016)
ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
S Abbara, A Arbab-Zadeh, TQ Callioster, MY Desai, W Mamuya, L Thomson, WG Weigold (2009)
SCCT guidelines for performance of coronary computed tomographic angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines CommitteeJ Cardiovasc Comput Tomogr., 3
V Schulze, S Steiner, M Hennersdorf, BE Strauer (2008)
Ivabradine as an alternative therapeutic trial in the therapy of inappropriate sinus tachycardia: a case reportCardiology., 110
A. Guaricci, E. Maffei, N. Brunetti, D. Montrone, L. Biase, C. Tedeschi, G. Gentile, L. Macarini, M. Midiri, Filippo Cademartiri, M. Biase (2013)
Heart rate control with oral ivabradine in computed tomography coronary angiography: a randomized comparison of 7.5 mg vs 5 mg regimen.International journal of cardiology, 168 1
Z. Abdel-Salam, W. Nammas (2016)
Atrial Fibrillation After Coronary Artery Bypass Surgery: Can Ivabradine Reduce Its Occurrence?Journal of Cardiovascular Electrophysiology, 27
E. Kaplinsky, Francesc Comes, L. Urondo, Francesc Ayma (2010)
Efficacy of ivabradine in four patients with inappropriate sinus tachycardia: a three month-long experience based on electrocardiographic, Holter monitoring, exercise tolerance and quality of life assessments.Cardiology journal, 17 2
C. Yancy, M. Jessup, B. Bozkurt, J. Butler, D. Casey, M. Drazner, G. Fonarow, S. Geraci, T. Horwich, J. Januzzi, Maryl Johnson, E. Kasper, W. Levy, F. Masoudi, P. Mcbride, J. McMurray, J. Mitchell, Pamela Peterson, B. Riegel, F. Sam, L. Stevenson, W. Tang, E. Tsai, B. Wilkoff (2013)
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.Journal of the American College of Cardiology, 62 16
P. Pichler, E. Pichler-Cetin, Markus Vertesich, H. Mendel, H. Sochor, W. Dock, B. Syeda (2012)
Ivabradine versus metoprolol for heart rate reduction before coronary computed tomography angiography.The American journal of cardiology, 109 2
S. Zellerhoff, M. Hinterseer, Bastian Krull, E. Schulze-Bahr, L. Fabritz, G. Breithardt, P. Kirchhof, S. Kääb (2010)
Ivabradine in patients with inappropriate sinus tachycardiaNaunyn-Schmiedeberg's Archives of Pharmacology, 382
C. Yancy, M. Jessup, B. Bozkurt, J. Butler, D. Casey, M. Drazner, G. Fonarow, S. Geraci, T. Horwich, J. Januzzi, Maryl Johnson, E. Kasper, W. Levy, F. Masoudi, P. Mcbride, J. McMurray, J. Mitchell, Pamela Peterson, B. Riegel, F. Sam, L. Stevenson, W. Tang, E. Tsai, B. Wilkoff (2013)
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.Circulation, 128 16
A. Franco, F. Sarullo, Y. Salerno, S. Figliozzi, R. Parrinello, P. Pasquale, G. Lanza (2014)
Beta-Blockers and Ivabradine in Chronic Heart Failure: From Clinical Trials to Clinical PracticeAmerican Journal of Cardiovascular Drugs, 14
C. January, L. Wann, J. Alpert, H. Calkins, J. Cigarroa, J. Cleveland, J. Conti, P. Ellinor, M. Ezekowitz, M. Field, K. Murray, R. Sacco, W. Stevenson, P. Tchou, C. Tracy, C. Yancy (2014)
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.Circulation, 130 23
J. Kosiuk, S. Oebel, Silke John, S. Hilbert, G. Hindricks, A. Bollmann (2015)
Ivabradine for rate control in atrial fibrillation.International journal of cardiology, 179
J. Tardif, P. Ponikowski, T. Kahan (2009)
Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trialEuropean Heart Journal, 30
Vipin Goyal, Suraj Godara, Trilok Sadasukhi, Hoti Gupta (2014)
Management of inappropriate sinus tachycardia with ivabradine in a renal transplant recipient.Drug discoveries & therapeutics, 8 3
O. Celik, MM Atasoy, M. Ertürk, AA Yalçın, H. Aksu, M. Diker, İF Aktürk, I. Atasoy (2014)
Single dose ivabradine versus intravenous metoprolol for heart rate reduction before coronary computed tomography angiography (CCTA) in patients receiving long-term calcium channel-blocker therapyActa Radiologica, 55
Le Mouroux, Le Métayer (1998)
Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.The New England journal of medicine, 339 10
Gabriel Retegui, Mario Quintero, Mariano Ruiz-Borrell, A. Revello (2009)
Ivabradina como alternativa terapéutica en la taquicardia sinusal inapropiadaRevista Espanola De Cardiologia, 62
L. Sargento, M. Satendra, S. Longo, N. Lousada, R. Reis (2014)
Heart Rate Reduction with Ivabradine in Patients with Acute Decompensated Systolic Heart FailureAmerican Journal of Cardiovascular Drugs, 14
K. Fox, I. Ford, P. Steg, J. Tardif, M. Tendera, R. Ferrari (2014)
Ivabradine in stable coronary artery disease without clinical heart failure.The New England journal of medicine, 371 12
L. Calò, M. Rebecchi, Antonella Sette, A. Martino, E. Ruvo, L. Sciarra, L. Luca, L. Zuccaro, G. Giunta, A. Ciccaglioni, E. Lioy, F. Fedele (2010)
Efficacy of ivabradine administration in patients affected by inappropriate sinus tachycardia.Heart rhythm, 7 9
Filippo Cademartiri, N. Mollet, G. Runza, M. Belgrano, P. Malagutti, B. Meijboom, M. Midiri, P. Feyter, G. Krestin (2006)
Diagnostic accuracy of multislice computed tomography coronary angiography is improved at low heart ratesThe International Journal of Cardiovascular Imaging, 22
E. Canet, G. Lerebours, J. Vilaine (2011)
Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradineAnnals of the New York Academy of Sciences, 1222
G. Caminiti, C. Fossati, G. Rosano, M. Volterrani (2016)
Addition of ivabradine to betablockers in patients with atrial fibrillation: Effects on heart rate and exercise tolerance.International journal of cardiology, 202
N. Parakh, V. Chaturvedi, S. Kurian, S. Tyagi (2012)
Effect of ivabradine vs atenolol on heart rate and effort tolerance in patients with mild to moderate mitral stenosis and normal sinus rhythm.Journal of cardiac failure, 18 4
S. Rathore, J. Curtis, Yongfei Wang, M. Bristow, H. Krumholz (2003)
Association of serum digoxin concentration and outcomes in patients with heart failure.JAMA, 289 7
J. Benezet‐Mazuecos, J. Rubio, J. Farré, M. Quiñones, P. Sánchez-Borque, Ester Macia (2013)
Long‐Term Outcomes of Ivabradine in Inappropriate Sinus Tachycardia Patients: Appropriate Efficacy or Inappropriate PatientsPacing and Clinical Electrophysiology, 36
P. Ptaszyński, K. Kaczmarek, J. Ruta, T. Klingenheben, J. Wranicz (2013)
Ivabradine in the Treatment of Inappropriate Sinus Tachycardia in Patients after Successful Radiofrequency Catheter Ablation of Atrioventricular Node Slow PathwayPacing and Clinical Electrophysiology, 36
F. Roubille, B. Lattuca, D. Busseuil, F. Leclercq, J. Davy, É. Rhéaume, J. Tardif (2013)
Is ivabradine suitable to control undesirable tachycardia induced by dobutamine in cardiogenic shock treatment?Medical hypotheses, 81 2
S. Raj (2013)
Postural Tachycardia Syndrome (POTS)Circulation, 127
G. Perry, E. Brown, R. Thornton, T. Shiva, J. Hubbard, K. Reddy, J. Doherty, F. Cardello, A. Fast, M. Radford, J. Folger, G. Bhaskar, R. Zoble, Sridharan, R. Loungani, M. Gheorghiade, A. Hsieh, C. Tommaso, M. Mansuri, M. Guess, S. Akhtar, S. Wagner, K. Hagan, K. Mcintyre, P. Ruble, M. Moten, A. Riley, G. Pierpont, Anand, G. Patel, B. Puram, B. Eladasari, J. Karnegis, E. Gillie, M. Crawford, W. Graettinger, A. Shah, J. Sacco, M. Chaudhry, D. Dolen, N. Elsherif, S. BekheitSaad, E. Campos, J. Greene, Khanijo, U. Kumar, G. Mallis, S. Mookherjee, M. DibnerDunlap, S. Gupta, K. Danisa, U. Thadani, A. Tan, M. Rajachar, M. Amidi, M. Oreilly, C. Hassapoyannes, M. Davies, V. Kumar, D. Okerson, K. Ramanathan, B. Putatunda, A. Gollapudi, A. Montero, P. Mohanty, C. Lui, S. Thagirisa, R. Lee, T. Glatter, K. Bodine, D. Roberts, M. Bertoglio, G. Dennish, R. Sarma, G. Gregoratos, D. Rausch, W. Pitt, B. Kennelly, D. Fahrenholtz, R. Gordon, L. Horwitz, R. Rothbart, P. Nutting, L. Lutz, D. Copen, A. Rashkow, J. Babb, L. VanVoorhees, A. Silverman, M. Stillabower, A. Miller, H. NguyenPho, R. Safford, S. Fishman, J. Neiman, M. Stein, J. Dominguez, G. Abernathy, P. Nair, L. Goodman, T. Cook, W. Wickemeyer, D. Berkson, J. Mathew, H. Richman, D. Lubell, R. Lang, E. Zajac, R. Rosenstein, M. Silver, J. Shanes, K. Kelly, M. Pequignot, R. Campbell, P. Kirlin, D. Ziperman, D. Denny, L. Gamble, M. Weiss, P. Kaimal, R. Dhurandhar, H. Ventura, M. Godley, C. Pu, E. Schick, D. Barbour, D. Salmon, M. Goldstein, M. Effron, J. Fleg, K. Baughman, R. Weiss, K. Ericson, W. Sturrock, J. Heinsimer, G. Timmis, Shaler Smith, D. Shrestha, W. Duvernoy, J. Hickner, B. Lewis, T. OBrien, S. Yarows, H. Willens, D. Mast, T. Johnson, R. Rodeheffer, M. Siefert, L. Swenson, P. Denes, R. Gudapati, F. Charles, M. Rich, Beckham, W. Hamilton, P. Abele, D. Harper, R. O'Kelly, A. Forker, F. Kahl, B. Garrou, Te Klang, K. Popio, S. Mohiuddin, E. Pollak, A. Chiaramida, J. Gregory, L. Papa, J. Abrams, S. Ung, C. Jutila, R. Croke, S. Chiaramida, R. Lucariello, D. Rim, M. Goldberger, R. Kohn, S. Graham, E. Philbin, K. Sheesley, A. Nafziger, G. Macina, J. Hsueh, S. Zoneraich, A. Binder, C. Weinstein, J. Morrison, A. Cameron, E. Vanderbush, J. Brown, P. Pande, E. Lader, R. Kay, D. Bloomfield, T. Costantino, D. Heiselman, S. Radwany, Smith, R. Hobbs, T. Fraker, T. Frerking, A. Deleon, L. Christie, M. Toren, J. Grover, F. McBarron, D. Harris, R. McLean, L. Morris, J. Zatuchni, J. Boehmer, B. Clemson, H. Lipshutz, R. Small, R. Ufret, Je LugoRodriquez, A. Khan, M. Yousefian, G. Friesinger, D. Ely, J. Farmer, J. Young, R. Payne, R. Fowles, A. Lee, Y. Shalev, Albitar, G. Schroeder, L. Radant, T. Hankey, S. Rezkalla, D. Groden, K. Teo, D. Humen, D. Wong, P. Greenwood, T. Talibi, W. Hui, W. Klinke, M. Senaratne, M. Goeres, D. Hughes, M. Sayeed, D. Roth, Belenkie, D. Manyari, K. Borgersen, L. Read, D. Kinloch, R. Reid, N. Barber, B. Horner, G. Kenefick, R. Kuritzky, Imrie, K. Wagner, S. Rabkin, H. Mizgala, L. Tarry, A. Dodek, J. Kornder, T. Ashton, D. Barr, J. Dufton, R. Sweeny, A. Morris, R. Bessoudo, D. Marr, Milton, B. Thompson, Robinson, B. Sussex, M. Tobin, D. McMahon, D. Folkins, R. Crowell, L. Lalonde, C. Koilpillai, R. Hatheway, M. Oreilly, T. Machel, Hack, J. Stewart, P. Tanser, B. Sullivan, S. Hagar, B. Quinn, R. Davies, M. Baird, W. Williams, M. Lemay, L. Higginson, M. Turek, R. Sochowski, A. Weeks, M. Jacobs, R. Baigrie, M. DeVilla, G. Vértes, B. Bożek, J. Goode, A. Ricci, J. Swan, D. Fell, S. LevinoffRoth, J. Arnold, L. Patrick, R. Southern, C. Rinne, D. Brisbin, J. Deyoung, T. Baitz, S. Vizel, J. Minkowitz, P. Letarte, Y. Chan, K. Kwok, S. Nawaz, F. Ganjavi, L. Yao, J. Misterski, D. Raco, A. Hess, G. Kuruvilla, L. Silverberg, D. Borts, J. Fulop, M. Weingert, R. Carter, B. Sahay, J. Hickey, G. Lalonde, G. Gosselin, M. Bourassa, C. Goulet, M. Joyal, M. Méthé, G. Honos, D. Fitchett, A. Serpa, F. Sestier, G. Roberge, Y. Latour, C. Rondeau, D. Gossard, J. Lenis, R. Brossoit, L. Simard, F. Delage, P. Auger, D. Saulnier, P. Talbot, J. Beaudoin, J. Campeau, G. Pruneau, M. Tamilia, G. Boutros, B. Comeau, R. Starra, R. StHilaire, J. Veilleux, M. Mercier, J. Poulin, K. Maclellan, S. Lepage, J. Rouleau, N. Bruinsma, C. Lévesque, R. Delarochelliére, M. Leblanc, S. Kouz, G. Kiwan, M. LaForest, J. Brooks, G. Bouchard, P. Gervais, J. Brophy, J. Gagnon, N. Habib, A. Basu, A. Lutterodt, M. Khouri, R. Gorlin, D. Egan, R. Garg, S. Yusuf, T. Montague, T. Smith, J. Cohn, G. Dagenais, R. Davies, D. Johnstone, C. Fye, Sather, D. Deykin, G. Francis, J. Collins, W. Williford, B. Singh (1997)
The effect of digoxin on mortality and morbidity in patients with heart failure.The New England journal of medicine, 336 8
C. January, L. Wann, J. Alpert, H. Calkins, J. Cigarroa, J. Cleveland, J. Conti, P. Ellinor, M. Ezekowitz, M. Field, K. Murray, R. Sacco, W. Stevenson, P. Tchou, C. Tracy, C. Yancy (2014)
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.Journal of the American College of Cardiology, 64 21
Ruoyu Zhang, D. Bobylev, P. Stiefel, A. Haverich, C. Bara (2012)
Lasting reduction of heart transplant tachycardia with ivabradine is effective and well tolerated: results of 48-month studyClinical Research in Cardiology, 101
A. Hersi (2010)
Potentially New Indication of Ivabradine: Treatment of a Patient with Postural Orthostatic Tachycardia SyndromeThe Open Cardiovascular Medicine Journal, 4
Antonella Sette, A. Martino, E. Lioy, L. Calò (2010)
Efficacy of Ivabradine in a Case of Inappropriate Sinus Tachycardia and Ventricular DysfunctionJournal of Cardiovascular Electrophysiology, 21
V. Ewan, M. Norton, J. Newton (2007)
Symptom improvement in postural orthostatic tachycardia syndrome with the sinus node blocker ivabradine.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 9 12
A. Diaz, M. Bourassa, M. Guertin, J. Tardif (2005)
Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease.European heart journal, 26 10
R. Verrier, Rodolfo Bonatti, A. Silva, Julio Batatinha, B. Nearing, Gongxin Liu, S. Rajamani, D. Zeng, L. Belardinelli (2014)
If inhibition in the atrioventricular node by ivabradine causes rate-dependent slowing of conduction and reduces ventricular rate during atrial fibrillation.Heart rhythm, 11 12
K. Swedberg, M. Komajda, M. Böhm, J. Borer, M. Robertson, L. Tavazzi, I. Ford (2012)
Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.Journal of the American College of Cardiology, 59 22
C. McDonald, J. Frith, J. Newton (2011)
Single centre experience of ivabradine in postural orthostatic tachycardia syndrome.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 13 3
Y. Cavusoglu, U. Mert, A. Nadi̇r, F. Mutlu, Bektas Morrad, T. Ulus (2015)
Ivabradine treatment prevents dobutamine-induced increase in heart rate in patients with acute decompensated heart failureJournal of Cardiovascular Medicine, 16
G. Cocco, P. Jerie (2013)
Comparison Between Ivabradine and Low-Dose Digoxin in the Therapy of Diastolic Heart Failure with Preserved Left Ventricular Systolic FunctionClinics and Practice, 3
P. Ptaszyński, K. Kaczmarek, J. Ruta, T. Klingenheben, I. Cygankiewicz, J. Wranicz (2013)
Ivabradine in Combination With Metoprolol Succinate in the Treatment of Inappropriate Sinus TachycardiaJournal of Cardiovascular Pharmacology and Therapeutics, 18
K. Fox, I. Ford, G. Steg, M. Tendera, R. Ferrari (2008)
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trialThe Lancet, 372
O. Celik, M. Atasoy, M. Erturk, A. Yalçın, H. Aksu, M. Diker, F. Akturk, K. Erkanlı, I. Atasoy, A. Kiris (2014)
Comparison of different strategies of ivabradine premedication for heart rate reduction before coronary computed tomography angiography.Journal of cardiovascular computed tomography, 8 1
S. Abbara (2010)
SCCT guidelines for performance of coronary computed tomographic angiography: A report of the Society of Cardiovascular Computed Tomography Guidelines CommitteeYearbook of Diagnostic Radiology, 2010
P. Ptaszyński, K. Kaczmarek, J. Ruta, T. Klingenheben, J. Wranicz (2013)
Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 15 1
C. January, L. Wann, Joseph Alpert, H. Calkins, Joaquin Cigarroa, Joseph Cleveland, Jamie Conti, P. Ellinor, M. Ezekowitz, Michael Field, Katherine Murray, Ralph Sacco, William Stevenson, Patrick Tchou, C. Tracy, C. Yancy (2014)
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.Circulation, 130 23
W. Kosmala, D. Holland, A. Rojek, L. Wright, M. Przewłocka-Kosmala, T. Marwick (2013)
Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.Journal of the American College of Cardiology, 62 15
Riccardo Cappato, S. Castelvecchio, C. Ricci, E. Bianco, L. Vitali-Serdoz, T. Gnecchi-Ruscone, M. Pittalis, Luigi Ambroggi, M. Baruscotti, M. Gaeta, F. Furlanello, Dario Francesco, P. Lupo (2012)
Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation.Journal of the American College of Cardiology, 60 15
K. Suenari, Chen-Chuan Cheng, Yao-Chang Chen, Yung-Kuo Lin, Yukiko Nakano, Y. Kihara, Shih‐Ann Chen, Yi‐Jen Chen (2012)
Effects of Ivabradine on the Pulmonary Vein Electrical Activity and Modulation of Pacemaker Currents and Calcium HomeostasisJournal of Cardiovascular Electrophysiology, 23
J. Kaski, A. Carro (2015)
Faculty Opinions recommendation of 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope.
L. Speranza, S. Franceschelli, G. Riccioni (2012)
The Biological Effects of Ivabradine in Cardiovascular DiseaseMolecules, 17
M. Volterrani, G. Cice, G. Caminiti, C. Vitale, S. D'isa, P. Filardi, F. Acquistapace, G. Marazzi, M. Fini, G. Rosano (2011)
Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial).International journal of cardiology, 151 2
B. Grubb (2008)
Postural tachycardia syndrome.Circulation, 117 21
P. Winum, G. Cayla, M. Rubini, L. Beck, P. Messner-Pellenc (2009)
A Case of Cardiomyopathy Induced by Inappropriate Sinus Tachycardia and Cured by IvabradinePacing and Clinical Electrophysiology, 32
A. Doesch, S. Çelik, P. Ehlermann, L. Frankenstein, J. Zehelein, A. Koch, H. Katus, T. Dengler (2007)
Heart Rate Reduction After Heart Transplantation With Beta-Blocker Versus the Selective If Channel Antagonist IvabradineTransplantation, 84
Ruairidh Martin, O. Pogoryelova, M. Koref, J. Bourke, M. Teare, B. Keavney (2014)
Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trialsHeart, 100
W Kosmala, DJ Holland, A Rojek, L Wright, M Przewlocka-Kosmala, TH Marwick (2013)
Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fractionJ Am Coll Cardiol., 62
B. Karas, B. Grubb, Kathy Boehm, K. Kip (2000)
The Postural Orthostatic Tachycardia Syndrome: A Potentially Treatable Cause of Chronic Fatigue, Exercise Intolerance, and Cognitive Impairment in AdolescentsPacing and Clinical Electrophysiology, 23
J. Tardif, I. Ford, M. Tendera, M. Bourassa, K. Fox (2005)
Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.European heart journal, 26 23
Ivabradine is a unique medication recently approved in the USA for the treatment of select heart failure patients. It was first approved for use in several countries around the world over a decade ago as an anti-anginal agent, with subsequent approval for use in heart failure patients. Since ivabradine has selective activity blocking the I f currents in the sinus node, it can reduce heart rate without appreciable effects on blood pressure. Given this heart-rate-specific effect, it has been investigated in many off-label indications as an alternative to traditional heart-rate-reducing medications such as beta blockers and calcium channel blockers. We conducted searches of PubMed and Google Scholar for ivabradine, heart failure, HFrEF, HFpEF, angina, coronary artery disease, inappropriate sinus tachycardia, postural orthostatic hypotension, coronary computed tomography angiography and atrial fibrillation. We reviewed and included studies, case reports, and case series published between 1980 and June 2016 if they provided information relevant to the practicing clinician. In many cases, larger clinical trials are needed to solidify the benefit of ivabradine, although studies indicate benefit in most therapeutic areas explored to date. The purpose of this paper is to review the current labeled and off-label uses of ivabradine, with a focus on clinical trial data.
American Journal of Cardiovascular Drugs – Springer Journals
Published: Jul 12, 2016
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.